Insulin glargine and lixisenatide Subcutaneous and Verelan
Determining the interaction of Insulin glargine and lixisenatide Subcutaneous and Verelan and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin glargine / lixisenatide
Brand name: Soliqua 100/33
Synonyms: Insulin glargine and lixisenatide (Subcutaneous)
Generic Name: verapamil
Brand name: Calan, Calan SR, Isoptin SR, Verelan, Isoptin, Isoptin IV, Covera-HS, Verelan PM
Synonyms: Verelan (Oral)
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- Insulin glargine and lixisenatide Subcutaneous-Verelan PM
- Insulin glargine and lixisenatide Subcutaneous-Veripred 20
- Insulin glargine and lixisenatide Subcutaneous-Vermox
- Insulin glargine and lixisenatide Subcutaneous-Versacloz
- Insulin glargine and lixisenatide Subcutaneous-Versed
- Insulin glargine and lixisenatide Subcutaneous-Versed injection
- Verelan-Insulin glargine, recombinant Subcutaneous
- Verelan-Insulin glulisine
- Verelan-Insulin Glulisine (Cartridges and Pens)
- Verelan-Insulin Glulisine (Vials)
- Verelan-Insulin glulisine Subcutaneous
- Verelan-Insulin human inhaled Inhalation